G3BP: A promising target for cancer therapy

Yaoxue Xuebao

Volumn 45, Issue 8, 2010, Pages 945-951

  Zhang, Hao ^a   Shao, Rong Guang ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Anti cancer drug; Cancer therapy; G3BP; RasGAP; RNA metabolism

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HELICASE; PROTEIN G3BP; PROTEIN SH3; RAS PROTEIN; RIBONUCLEASE; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER INVASION; CANCER THERAPY; CELL DIFFERENTIATION; CELL GRANULE; CELL PROLIFERATION; CELL STRESS; GENE OVEREXPRESSION; METASTASIS; MOLECULARLY TARGETED THERAPY; NEOPLASM; PROTEIN EXPRESSION; REVIEW; RNA METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CARRIER PROTEINS; DRUG DELIVERY SYSTEMS; GTPASE-ACTIVATING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RAS GTPASE-ACTIVATING PROTEINS; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS;

EID: 77957916346     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Parker F, Maurier F, Delumeau I, et al. A Ras-GTPase-activating protein SH3-domain-binding protein [J]. Mol Cell Biol, 1996, 16: 2561-2569.
2. Kennedy D, French J, Guitard E, et al. Characterization of G3BPs: tissue specific expression, chromosomal localisation and rasGAP(120) binding studies [J]. J Cell Biochem, 2001, 84: 173-187.
3. Zekri L, Chebli K, Tourriere H, et al. Control of fetal growth and neonatal survival by the RasGAP-associated endoribonuclease G3BP [J]. Mol Cell Biol, 2005, 25: 8703-8716. (Pubitemid 41369188)
4. Kociok N, Esser P, Unfried K, et al. Upregulation of the RAS-GTPase activating protein (GAP)-binding protein (G3BP) in proliferating RPE cells [J]. J Cell Biochem, 1999, 74: 194-201. (Pubitemid 29307709)
5. Liu Y, Zheng J, Fang W, et al. Identification of metastasis associated gene G3BP by differential display in human cancer cell sublines with different metastatic potentials G3BP as highly expressed in non-metastatic [J]. Chin Med J (Engl), 2001, 114: 35-38. (Pubitemid 33636548)
6. Guitard E, Parker F, Millon R, et al. G3BP is overexpressed in human tumors and promotes S phase entry [J]. Cancer Lett, 2001, 162: 213-221. (Pubitemid 32056291)
7. French J, Stirling R, Walsh M, et al. The expression of Ras-GTPase activating protein SH3 domain-binding proteins, G3BPs, in human breast cancers [J]. Histochem J, 2002, 34: 223-231. (Pubitemid 36169484)
8. Barnes CJ, Li F, Mandal M, et al. Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors [J]. Cancer Res, 2002, 62: 1251-1255. (Pubitemid 34407772)
9. Quimby BB, Wilson CA, Corbett AH. The interaction between Ran and NTF2 is required for cell cycle progression [J]. Mol Biol Cell, 2000, 11: 2617-2629.
10. Quimby BB, Lamitina T, L'Hernault SW, et al. The mechanism of ran import into the nucleus by nuclear transport factor 2 [J]. J Biol Chem, 2000, 275: 28575-28582.
11. Prigent M, Barlat I, Langen H, et al. IkappaBalpha and IkappaBalpha/NF-kappa B complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2 [J]. J Biol Chem, 2000, 275: 36441-36449.
12. Macara IG. Transport into and out of the nucleus [J]. Microbiol Mol Biol Rev, 2001, 65: 570-594.
13. Tourrière H, Chebli K, Zekri L, et al. The RasGAP-associated endoribonuclease G3BP assembles stress granules [J]. J Cell Biol, 2003, 160: 823-831. (Pubitemid 36350838)
14. Birney E, Kumar S, Krainer AR. Analysis of the RNA-recognition motif and RS and RGG domains: conservation in metazoan pre-mRNA splicing factors [J]. Nucleic Acids Res, 1993, 21: 5803-5816. (Pubitemid 24023691)
15. Kennedy D, Wood SA, Ramsdale T, et al. Identification of a mouse orthologue of the human ras-GAP-SH3-domain binding protein and structural confirmation that these proteins contain an RNA recognition motif [J]. Biomed Pept Proteins Nucleic Acids, 1996, 2: 93-99.
16. Burd CG, Dreyfuss G. Conserved structures and diversity of functions of RNA-binding proteins [J]. Science, 1994, 265: 615-621. (Pubitemid 24268271)
17. Darnell JC, Jensen KB, Jin P, et al. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function [J]. Cell, 2001, 107: 489-499. (Pubitemid 33152784)
18. Saksela K, Cheng G, Baltimore D. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4 [J]. EMBO J, 1995, 14: 484-491.
19. Yang JY, Widmann C. The RasGAP N-terminal fragment generated by caspase cleavage protects cells in a Ras/PI3K/Akt-dependent manner that does not rely on NFkappa B activation [J]. J Biol Chem, 2002, 277: 14641-14646. (Pubitemid 34952532)
20. Tocque B, Delumeau I, Parker F, et al. Ras-GTPase activating protein (GAP): a putative effector for Ras [J]. Cell Signal, 1997, 9: 153-158. (Pubitemid 27186914)
21. Leblanc V, Delumeau I, Tocque B. Ras-GTPase activating protein inhibition specifically induces apoptosis of tumour cells [J]. Oncogene, 1999, 18: 4884-4889. (Pubitemid 29423572)
22. Lypowy J, Chen IY, Abdellatif M. An alliance between Ras GTPase-activating protein, filamin C, and Ras GTPase-activating protein SH3 domain-binding protein regulates myocyte growth [J]. J Biol Chem, 2005, 280: 25717-25728. (Pubitemid 40962281)
23. Gallouzi IE, Parker F, Chebli K, et al. A novel phosphorylation- dependent RNase activity of GAP-SH3 binding protein: a potential link between signal transduction and RNA stability [J]. Mol Cell Biol, 1998, 18: 3956-3965. (Pubitemid 28287919)
24. Tourriere H, Gallouzi IE, Chebli K, et al. RasGAP-associated endoribonuclease G3Bp: selective RNA degradation and phosphorylation-dependent localization [J]. Mol Cell Biol, 2001, 21: 7747-7760. (Pubitemid 32988784)
25. Brewer G. Regulation of c-myc mRNA decay in vitro by a phorbol ester-inducible, ribosome-associated component in differentiating megakaryoblasts [J]. J Biol Chem, 2000, 275: 33336-33345.
26. Irvine K, Stirling R, Hume D, et al. Rasputin, more promiscuous than ever: a review of G3BP [J]. Int J Dev Biol, 2004, 48: 1065-1077. (Pubitemid 40179573)
27. Arimoto K, Fukuda H, Imajoh-Ohmi S, et al. Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways [J]. Nat Cell Biol, 2008, 10: 1324-1332.
28. Huang Y, Wernyj RP, Norton DD, et al. Modulation of specific protein expression levels by PTEN: identification of AKAP121, DHFR, G3BP, Rap1, and RCC1 as potential targets of PTEN [J]. Oncogene, 2005, 24: 3819-3829. (Pubitemid 40826880)
29. Kim MM, Wiederschain D, Kennedy D, et al. Modulation of p53 and MDM2 activity by novel interaction with Ras-GAP binding proteins (G3BP) [J]. Oncogene, 2007, 26: 4209-4215. (Pubitemid 46975801)
30. Levine AJ. p53, the cellular gatekeeper for growth and division [J]. Cell, 1997, 88: 323-331.
31. Soncini C, Berdo I, Draetta G. Ras-GAP SH3 domain binding protein (G3BP) is a modulator of USP10, a novel human ubiquitin specific protease [J]. Oncogene, 2001, 20: 3869-3879. (Pubitemid 32646197)
32. Cohen M, Stutz F, Dargemont C. Deubiquitination, a new player in Golgi to endoplasmic reticulum retrograde transport [J]. J Biol Chem, 2003, 278: 51989-51992. (Pubitemid 38035783)
33. Cohen M, Stutz F, Belgareh N, et al. Ubp3 requires a cofactor, Bre5, to specifically de-ubiquitinate the COPII protein, Sec23 [J]. Nat Cell Biol, 2003, 5: 661-667. (Pubitemid 36818089)
34. Schmitz AA, Govek EE, Bottner B, et al. Rho GTPases: signaling, migration, and invasion [J]. Exp Cell Res, 2000, 261: 1-12.
35. Hanahan D, Weinberg RA. The hallmarks of cancer [J]. Cell, 2000, 100: 57-70.
36. Zhang HZ, Liu JG, Wei YP, et al. Expression of G3BP and RhoC in esophageal squamous carcinoma and their effect on prognosis [J]. World J Gastroenterol, 2007, 13: 4126-4130. (Pubitemid 47323170)
37. Clark EA, Golub TR, Lander ES, et al. Genomic analysis of metastasis reveals an essential role for RhoC [J]. Nature, 2000, 406: 532-535.
38. Yang JY, Widmann C. A subset of caspase substrates functions as the Jekyll and Hyde of apoptosis [J]. Eur Cytokine Netw, 2002, 13: 404-406. (Pubitemid 36174096)
39. Yang JY, Michod D, Walicki J, et al. Partial cleavage of RasGAP by caspases is required for cell survival in mild stress conditions [J]. Mol Cell Biol, 2004, 24: 10425-10436. (Pubitemid 39507879)
40. Michod D, Yang JY, Chen J, et al. A RasGAP-derived cell permeable peptide potently enhances genotoxin-induced cytotoxicity in tumor cells [J]. Oncogene, 2004, 23: 8971-8978. (Pubitemid 39657787)
41. Michod D, Widmann C. TAT-RasGAP317-326 requires p53 and PUMA to sensitize tumor cells to genotoxins [J]. Mol Cancer Res, 2007, 5: 497-507. (Pubitemid 46903957)
42. Pittet O, Petermann D, Michod D, et al. Effect of the TAT-RasGAP(317-326) peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetrahydroxyphenyl-chlorin and light [J]. J Photochem Photobiol B, 2007, 88: 29-35.
43. Michod D, Annibaldi A, Schaefer S, et al. Effect of RasGAP N2 fragment-derived peptide on tumor growth in mice [J]. J Natl Cancer Inst, 2009, 101: 828-832.
44. Pomerance M, Thang MN, Tocque B, et al. The RasGTPase-activating protein SH3 domain is required for Cdc2 activation and mos induction by oncogenic Ras in Xenopus oocytes independently of mitogen-activated protein kinase activation [J]. Mol Cell Biol, 1996, 16: 3179-3186.
45. Cui W, Wei Z, Chen Q, et al. Structure-based design of peptides against G3BP with cytotoxicity on tumor cells [J]. J Chem Inf Model, 2010, 50: 380-387.
46. Parker F, Kenigsberg M, Duchesne M, et al. Monoclonal antibodies directed against the G3BP protein, and uses: US, 7001980B1 [P], 2006-02-21.